CED Life Science Conference 2017 - Innovation Room
Sub-sector: Biotech and Pharmaceutical
Year Founded: 2016
BioLink Life Sciences is a biopharmaceutical technology company targeting major diseases with innovative drug treatments. BioLink’s exclusive drug therapies support disease management initiatives to enhance the quality of life and care of patients while improving patient tolerability and decreasing drug costs. The Company is developing a robust pipeline of novel treatments for osteoporosis, iron deficiencies, kidney disease, diabetes, and seizure disorders.
Deanna J. Nelson, President
KEY MILESTONES TO DATE
- Funding: $4MM from SBIR grants, $2MM from founder
- Filed patent on novel treatment for bone maintenance & repair
- Developed 3 new dietary supplements useful to keep the elderly healthy
- Filed Phase 2 SBIR grant that was awarded but not funded
Learn more about the CED Life Science Conference.